WINTERTHUR, Switzerland--(BUSINESS WIRE)--Cardiola AG announced today that it has raised an additional $4 million from existing and new investors. Together with the $2.3 million raised earlier this year, the total cash infusion of $6.3 million is part of the first tranche of a $7.9 million Series “E” financing round. The proceeds are being used to commercialize in Europe the Company’s patented m.pulse® device designed to non-surgically treat Chronic Heart Failure (CHF) in a patient’s home.
